Health Care & Life Sciences » Pharmaceuticals » Novartis | Novartis R&D spending by business 2017

Novartis' spending on research and development by division 2016-2017

Novartis AG's spending on research and development by division in 2016 and 2017 (Figures expressed in billions of U.S. dollars, unless otherwise specified)

The data displays the expenditure on research and development of pharmaceutical company Novartis from in 2016 and 2017, by business segment. In both years, the company spent around seven billion USD for research and development in the Innovative Medicines division.

Innovative Medicines 7.11 7.05
Sandoz 0.8 0.77
Alcon 0.49 0.49

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.